Lv7
4460 积分 2024-08-20 加入
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
2个月前
已完结
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™
4个月前
已完结
Hetero-bivalent agents targeting FAP and PSMA
5个月前
已完结
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
6个月前
已完结
Preclinical positron emission computed tomography of prolonged tumor growth after lutetium-177 prostate-specific membrane antigen treatment in xenograft model of human prostate cancer
6个月前
已关闭
Biodistribution of 177Lu-DOTA-PSMA in Mice with Prostate Carcinoma 22Rv1
6个月前
已完结
PSMA and Sigma-1 receptor dual-targeted peptide mediates superior radionuclide imaging and therapy of prostate cancer
6个月前
已完结
Rethinking therapeutic strategies of dual-target drugs: An update on pharmacological small-molecule compounds in cancer
6个月前
已完结
皖公网安备34019202002308
